Prof. Farhad Hafezi
September 7, 2022
People with Down Syndrome have a disproportionately higher risk of developing keratoconus than the general population, and many go on to receive corneal cross-linking (CXL)
TouchOphthalmology interviewed Prof. Farhad Hafezi on why it’s taken until now to have an effective epi-on CXL solution.
The Tear Film & Ocular Surface Society (TFOS) is a non-profit organization, created with the aim of advancing the field of tear film and ocular
Prof. Farhad Hafezi, Medical Director of the ELZA Institute, Zurich, Switzerland was the second-placed winner of the VSY Biotechnology’s Ophthalmology Star awards 2021, presented at
Prof. Amar Agarwal, editor of Ocular Surgery News, reports on corneal cross-linking at the slit lamp together with Prof. Farhad Hafezi. See the link here.
The reason why ELZA is an international leader in eye care is that we have superb clinicians… who also are also superb and prolific academic researchers. Last year, our clinicians published 68 unique papers – four more than in 2019, our previous record-breaking year!
ELZA takes observerships seriously. When we offer somebody an observership placement, we’ll plan that person’s time carefully to give them the maximum exposure to the clinical, scientific and administrative aspects of the clinic.
